Perilipin5 protects against non-alcoholic steatohepatitis by increasing 11-Dodecenoic acid and inhibiting the occurrence of ferroptosis
Non-alcoholic steatohepatitis (NASH) is a major contributor to liver cirrhosis and hepatocellular carcinoma. There remains no effective pharmacological therapy. The hepatic lipid metabolism and fatty acid β-ox...
Source: Nutrition and Metabolism - Category: Nutrition Authors: Xinming Xu, Jin Qiu, Xiaoya Li, Juntong Chen, Yue Li, Xinmei Huang, Shufei Zang, Xinran Ma and Jun Liu Tags: Research Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Cirrhosis | Hepatocellular Carcinoma | Liver | Liver Cancer | Nutrition | Urology & Nephrology